ADVANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sector of biopharmaceuticals, providing promising developments throughout numerous health-related and industrial apps. With its structural similarity to Obviously derived human serum albumin, OsrHSA provides a safer, much more trustworthy alternative for therape